期刊
CELLS
卷 9, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/cells9030592
关键词
cardiac fibrosis; heart failure; extracellular vesicle (EVs); EVs engineering; exosomes; microRNAs; noncoding RNAs; stem cells
类别
资金
- University of Verona, Italy
- EEU-Cardiac RNA cost action [CA17129]
- British Heart Foundation: BHF Centre of Vascular Regeneration [RG/15/5/31446, CH/15/1/31199]
- Italian Ministry of Health
- Telethon Foundation [GGP19035A]
- BHF Centre of Regenerative Medicine
Fibrosis is a significant global health problem associated with many inflammatory and degenerative diseases affecting multiple organs, individually or simultaneously. Fibrosis develops when extracellular matrix (ECM) remodeling becomes excessive or uncontrolled and is associated with nearly all forms of heart disease. Cardiac fibroblasts and myofibroblasts are the main effectors of ECM deposition and scar formation. The heart is a complex multicellular organ, where the various resident cell types communicate between themselves and with cells of the blood and immune systems. Exosomes, which are small extracellular vesicles, (EVs), contribute to cell-to-cell communication and their pathophysiological relevance and therapeutic potential is emerging. Here, we will critically review the role of endogenous exosomes as possible fibrosis mediators and discuss the possibility of using stem cell-derived and/or engineered exosomes as anti-fibrotic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据